RDWR.NASDAQRadware LTD

SCHEDULE 13G: Roy Zisapel Discloses Over 5% Beneficial Ownership in Radware Ltd. Following Share Inheritance

Sentiment:

Beneficial Ownership Report


Roy Zisapel has filed a Schedule 13G, disclosing a 5.06% beneficial ownership stake in Radware Ltd., primarily due to inherited shares.

Summary

  • Roy Zisapel, an Israeli citizen, has filed a Schedule 13G indicating beneficial ownership of 2,162,244 ordinary shares of Radware Ltd.
  • This ownership represents 5.06% of Radware Ltd.'s outstanding ordinary shares, based on 42,686,534 shares issued as of March 21, 2025.
  • The reported beneficial ownership includes 2,102,292 ordinary shares and options to purchase an additional 59,952 shares at an exercise price of $16.68 per share.
  • The filing was triggered because Mr. Zisapel's total beneficial ownership exceeded 5% of the company's outstanding shares after inheriting shares.
  • His acquisitions during the 12-month period preceding this event did not exceed two percent of the company's outstanding shares.
  • Mr. Zisapel holds sole voting and sole dispositive power over the reported 2,162,244 shares.
  • He disclaims beneficial ownership of an additional 324,500 shares ("Neurim Shares") held by Neurim Pharmaceuticals (1991) Ltd., where his mother and siblings also hold interests, except to the extent of his pecuniary interest.

Sentiment

Score: 5

Explanation: The document is a factual disclosure of beneficial ownership, which is neutral in sentiment.

Future Outlook

NA

Industry Context

NA

Related Party Transactions

  • Roy Zisapel disclaims beneficial ownership of 324,500 shares (the "Neurim Shares") held by Neurim Pharmaceuticals (1991) Ltd., an Israeli company.
  • Neurim Pharmaceuticals (1991) Ltd. is 50% held by Nava Zisapel (Mr. Zisapel's mother) and 50% held in three equal parts by Roy Zisapel and his siblings, indicating a related party relationship.

Stakeholder Impact

  • Shareholders: Provides transparency regarding a significant individual shareholder's stake, which can influence market perception and corporate control dynamics.

Key Dates

DateDescription
12/31/2024Date of event which requires filing of this statement
03/21/2025Date as of which 42,686,534 ordinary shares of Radware Ltd. were issued and outstanding
03/28/2025Date Radware Ltd.'s Annual Report on Form 20-F was filed with the SEC, reporting the outstanding shares
04/24/2025Date of signature/filing of this Schedule 13G

Keywords

Radware Ltd, Roy Zisapel, Schedule 13G, Beneficial Ownership, Ordinary Shares, SEC Filing, Shareholder, Israel, M81873107

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.